IL17A and psoriasis: <i>In vivo</i>, 3D-hUC-MSCs significantly reduced IMQ+IL-23-induced psoriasis-like skin inflammation by reducing immune cell infiltration and inhibiting IL-17-associated inflammatory pathways.